Ecolab Inc. operates in 3 segments: Global Industrial; Global Institutional & Specialty; and Global Healthcare & Life Sciences.
Paying user area
Try for free
Ecolab Inc. pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Profitability Ratios
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Selected Financial Data since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
- Price to Sales (P/S) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Ecolab Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Segment Profit Margin
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Global Industrial | |||||
Global Institutional & Specialty | |||||
Global Healthcare & Life Sciences |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Global Industrial | Global Industrial segment profit margin ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021 not reaching 2019 level. |
Global Institutional & Specialty | Global Institutional & Specialty segment profit margin ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. | |
Global Healthcare & Life Sciences | Global Healthcare & Life Sciences segment profit margin ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021. |
Segment Profit Margin: Global Industrial
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | |||||
Operating income (loss) | |||||
Net sales | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Global Industrial | Global Industrial segment profit margin ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021 not reaching 2019 level. |
Segment Profit Margin: Global Institutional & Specialty
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | |||||
Operating income (loss) | |||||
Net sales | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Global Institutional & Specialty | Global Institutional & Specialty segment profit margin ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Segment Profit Margin: Global Healthcare & Life Sciences
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | |||||
Operating income (loss) | |||||
Net sales | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Global Healthcare & Life Sciences | Global Healthcare & Life Sciences segment profit margin ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021. |
Net sales
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Global Industrial | |||||
Global Institutional & Specialty | |||||
Global Healthcare & Life Sciences | |||||
Global Energy | |||||
Other | |||||
Corporate | |||||
Subtotal at fixed currency | |||||
Effect of foreign currency translation | |||||
Consolidated reported GAAP |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Operating income (loss)
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Global Industrial | |||||
Global Institutional & Specialty | |||||
Global Healthcare & Life Sciences | |||||
Global Energy | |||||
Other | |||||
Corporate | |||||
Subtotal at fixed currency | |||||
Effect of foreign currency translation | |||||
Consolidated reported GAAP |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).